Cocrystal Pharma, Inc. (COCP) Financials
COCP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 7.4 million | 3.3 million |
| Dec. 31, 2025 | 9.7 million | 3.4 million |
| Sept. 30, 2025 | 10.4 million | 2.8 million |
| June 30, 2025 | 8.5 million | 3.2 million |
COCP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -2.3 million | 84000 |
| Dec. 31, 2025 | -1.7 million | 56000 |
| Sept. 30, 2025 | -1.6 million | 48000 |
| June 30, 2025 | -2.2 million | 84000 |
COCP Net Income
No data available :(
COCP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.7 million | - | 1.1 million |
| Dec. 31, 2025 | 7.0 million | - | 1.5 million |
| Sept. 30, 2025 | 7.7 million | - | 1.6 million |
| June 30, 2025 | 4.8 million | - | 1.7 million |
COCP Shares Outstanding
COCP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.4 million | 1.2 million | - |
| Dec. 31, 2025 | - | 1.6 million | 862000 | 39000 |
| Sept. 30, 2025 | 12561 | 954000 | 1.1 million | - |
| June 30, 2025 | - | 1.1 million | 986000 | - |
COCP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 225000 | 91000 |
| Dec. 31, 2025 | - | -1.4 million |
| Sept. 30, 2025 | - | 13000 |
| June 30, 2025 | - | 21000 |
COCP Revenue by Segment
Graph available only for paid members. Upgrade to see it.
COCP
Price: $0.99
52 week price:
Earnings Per Share: -0.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 92200
Market Capitalization: 10.8 million